Horizon

Horizon is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative medicines that address critical needs for people impacted by rare and rheumatic diseases. They generate revenue primarily through the sales of their proprietary drugs, which include treatments for conditions such as thyroid eye disease and gout. Founded in 2008, Horizon has grown significantly through strategic acquisitions and partnerships, enhancing their portfolio and expanding their global reach. Their commitment to patient-centric solutions and robust R&D pipeline positions them as a leader in the biopharmaceutical industry.

Recent Posts by Horizon

1-20 of 122